Quantum Biopharma (NASDAQ:QNTM) Shares Down 3% – Should You Sell?

Quantum Biopharma Ltd. (NASDAQ:QNTM) shares fell 3% on Tuesday . The stock traded as low as $3.20 and last traded at $3.28. 38,874 shares were traded during trading, a decline of 45% from the average session volume of 70,708 shares. The stock had previously closed at $3.38.

Quantum Biopharma Price Performance

The stock has a market cap of $6.29 million, a P/E ratio of -0.21 and a beta of 0.60. The firm has a 50-day simple moving average of $4.30.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Quantum Biopharma stock. Virtu Financial LLC bought a new position in Quantum Biopharma Ltd. (NASDAQ:QNTM) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,428 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned approximately 0.60% of Quantum Biopharma as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 1.24% of the company’s stock.

About Quantum Biopharma

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments.